Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

B-cell Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Seoul National University Hospital, Seoul, South Korea
Contact: Study coordinator (Hyoung Jin Kang, MD, PhD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

B-cell Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE3

New York, United States · Cincinnati, United States

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Hematologic Malignancy · Large B-cell Lymphoma · Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Beijing, China

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Lymphoblastic Leukemia, Acute, Childhood · Lymphoblastic Leukemia · Lymphoblastic Leukemia, Acute Adult

Abroad (travel likely)RecruitingPHASE1

Singapore, Singapore